These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20840454)

  • 1. Acceptance of drug-drug interaction alerts and alert system design.
    Eslami S; Abu-Hanna A
    Br J Clin Pharmacol; 2010 Oct; 70(4):619-20. PubMed ID: 20840454
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency and nature of drug-drug interactions in a Dutch university hospital.
    Zwart-van Rijkom J; Uijtendaal E; Ten Berg M; Van Solinge W; Egberts A
    Br J Clin Pharmacol; 2010 Oct; 70(4):618. PubMed ID: 20840453
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency and nature of drug-drug interactions in a Dutch university hospital.
    Zwart-van Rijkom JE; Uijtendaal EV; ten Berg MJ; van Solinge WW; Egberts AC
    Br J Clin Pharmacol; 2009 Aug; 68(2):187-93. PubMed ID: 19694737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.
    Rommers MK; Teepe-Twiss IM; Guchelaar HJ
    Drug Saf; 2011 Mar; 34(3):233-42. PubMed ID: 21332247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients.
    Zenziper Straichman Y; Kurnik D; Matok I; Halkin H; Markovits N; Ziv A; Shamiss A; Loebstein R
    Int J Med Inform; 2017 Nov; 107():70-75. PubMed ID: 29029694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts.
    Nishimura AA; Shirts BH; Salama J; Smith JW; Devine B; Tarczy-Hornoch P
    Int J Med Inform; 2016 Feb; 86():117-25. PubMed ID: 26642939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
    Buurma H; De Smet PA; Egberts AC
    Drug Saf; 2006; 29(8):723-32. PubMed ID: 16872246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' responses to computerized drug interaction alerts with password overrides.
    Nasuhara Y; Sakushima K; Endoh A; Umeki R; Oki H; Yamada T; Iseki K; Ishikawa M
    BMC Med Inform Decis Mak; 2015 Aug; 15():74. PubMed ID: 26315024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overrides of medication alerts in ambulatory care.
    Isaac T; Weissman JS; Davis RB; Massagli M; Cyrulik A; Sands DZ; Weingart SN
    Arch Intern Med; 2009 Feb; 169(3):305-11. PubMed ID: 19204222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative analysis of prescription activity and alert usage in a computerized physician order entry system.
    Wipfli R; Betrancourt M; Guardia A; Lovis C
    Stud Health Technol Inform; 2011; 169():940-4. PubMed ID: 21893884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician's expectations regarding prescribing clinical decision support systems in a Belgian hospital.
    Cornu P; Steurbaut S; De Beukeleer M; Putman K; van de Velde R; Dupont AG
    Acta Clin Belg; 2014 Jun; 69(3):157-64. PubMed ID: 24820921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of drug-drug interactions : a structured assessment procedure.
    van Roon EN; Flikweert S; le Comte M; Langendijk PN; Kwee-Zuiderwijk WJ; Smits P; Brouwers JR
    Drug Saf; 2005; 28(12):1131-9. PubMed ID: 16329715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of provider characteristics on the responses to medication-related decision support alerts.
    Cho I; Slight SP; Nanji KC; Seger DL; Maniam N; Fiskio JM; Dykes PC; Bates DW
    Int J Med Inform; 2015 Sep; 84(9):630-9. PubMed ID: 26004341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide variation and patterns of physicians' responses to drug-drug interaction alerts.
    Cho I; Lee Y; Lee JH; Bates DW
    Int J Qual Health Care; 2019 Mar; 31(2):89-95. PubMed ID: 29741633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Think time: A novel approach to analysis of clinicians' behavior after reduction of drug-drug interaction alerts.
    Schreiber R; Gregoire JA; Shaha JE; Shaha SH
    Int J Med Inform; 2017 Jan; 97():59-67. PubMed ID: 27919396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting and preventing adverse drug reactions in managed care.
    Navarro RP
    Med Interface; 1996 May; 9(5):80-1. PubMed ID: 10157689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.